Natco Pharma Of India Buys U.S.-Based Newark Drugs
This article was originally published in PharmAsia News
Executive Summary
India's Natco Pharma says it has bought the assets of Newark Drugs drugstore chain in the U.S. The purchase price was not announced, but Newark Drugs has about $5 million in annual sales. The acquisition, which was made through the K&C Pharmacy general partnership in which Natco has 75 percent ownership, would be the India company's third since 2006. Natco's other property buys were Nicks' Drugs and SaveMart Drugs. (Click here for more